IBT

International Biotechnology Trust Portfolio holdings

AUM $297M
1-Year Est. Return 17.25%
This Quarter Est. Return
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$6.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
74
New
Increased
Reduced
Closed

Top Buys

1
+$4.85M
2
+$4.33M
3
+$4.09M
4
NBIX icon
Neurocrine Biosciences
NBIX
+$4.04M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.88M

Top Sells

1
+$7.11M
2
+$5.43M
3
+$5.4M
4
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
+$5.01M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.63M

Sector Composition

1 Healthcare 91.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$725K 0.28%
18,799
-96,000
52
$718K 0.28%
14,779
-79,043
53
$478K 0.19%
+25,000
54
$413K 0.16%
18,000
55
$334K 0.13%
+3,209
56
$178K 0.07%
+425
57
– –
-14,023
58
– –
-27,000
59
– –
-54,000
60
– –
-60,946
61
– –
-16,000
62
– –
-42,000
63
– –
-62,905
64
– –
-140,000
65
– –
-1,763
66
– –
-11,155
67
– –
-20,500
68
– –
-161,069
69
– –
-9,200
70
– –
-358,975
71
– –
-22,100
72
– –
-32,700
73
– –
-168,025
1 2
3